A drug used to treat malaria does not, after all, create new insulin-producing cells, according to a new paper published in Cell Metabolism, refutes a study published in Cell in January.
"First we had hoped that we would be able to replicate the findings, but they didn't hold up," said the senior author. "People with Type 1 diabetes, they see these stories come out and they think maybe there's something on the horizon and then nothing ever follows through," senior author said.
The symptoms of Type 1 and Type 2 diabetes are quite similar but the underlying causes differ. In type 1 diabetes, the body fails to create enough insulin, a hormone produced by the pancreas that regulates cellular intake of nutrients. In Type 2 diabetes, cells no longer respond efficiently to insulin.
Insulin is produced in hormone-producing regions of the pancreas called islets. Within the islets are alpha and beta cells. Beta cells are integral to creating insulin.
"That's the cell that if you lose (insulin production), you get Type 1 diabetes," said the senior author. So there is always interest in any process that might generate new beta cells to replace those lost in Type 1 diabetes.
In early 2017, in a paper published in the journal Cell, a European team reported that the antimalarial drug artemether could convert alpha cells into functional beta cells. While alpha cells converting into beta cells had been described before, this was the first time an existing drug had been reported to stimulate the process and it caused a lot of excitement in the field, senior author said.
Outfitted with the precision tools to capture alpha-to-beta cellular conversion, senior author enlisted graduate student to assist with replicating the original experiment.
"We were hoping, expecting, to confirm," senior author said. "We weren't able to."
The grad student used pancreatic islets derived from mice. After around four months of experiments with artemether, it was clear that the drug was not triggering alpha to beta cell conversion, as the initial Cell paper had claimed.
The Cell paper suggested that the widely used anti-malaria drug artemether suppresses the α cell transcription factor Arx to promote transdifferentiation into β cells. However, key initial experiments in this paper were carried out in islet cell lines, and most subsequent validation experiments implied transdifferentiation without direct demonstration of α to β cell conversion.
Indeed, the authors founnd no evidence that artemether promotes transdifferentiation of primary α cells into β cells. Moreover, artemether reduces Ins2 expression in primary β cells >100-fold, suppresses glucose uptake, and abrogates β cell calcium responses and insulin secretion in response to glucose.These observations suggest that artemether induces general islet endocrine cell dedifferentiation,
The new paper highlights the importance of reproducibility, a perennial and hotly contested topic of concern at all levels of scientific research. It also demonstrates how routine lab assignments meant to educate students can provide the foundations for published research.
"It's important to realize that our work has an impact in the real world," senior author said. "We should continuously strive to hold ourselves and our peers to a higher standard, particularly when we talk about discoveries that promise a possible cure for diabetes."
https://www.ucdavis.edu/news/study-refutes-using-anti-malaria-drug-treat-diabetes
http://www.cell.com/cell-metabolism/fulltext/S1550-4131(17)30614-9
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Secret tunnels to communicate and smuggle cancer signals to their n…
Read more
Skin cancer-causing fusion gene identified
Read more
Improved photodynamic therapy to kill cancer cells
Read more
DNA in blood can track cancer development and response in real time
Read more
Cell's mechanism to cope with the loss of TCA cycle enzyme, succina…
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Regulation of Zbp1 by miR-9…
By newseditor
Posted 27 Mar
Pain-free oral delivery of…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar